Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
Zellars RC, Stearns V, Frassica D, Asrari F, Tsangaris T, Myers L, DiPasquale S, Lange JR, Jacobs LK, Emens LA, Armstrong DK, Fetting JH, Garrett-Mayer E, Davidson NE, Wolff AC. Zellars RC, et al. Among authors: jacobs lk. J Clin Oncol. 2009 Jun 10;27(17):2816-22. doi: 10.1200/JCO.2008.20.0139. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332718 Free PMC article.
Sorting through the heterogeneity of recurrent melanoma.
Jacobs LK, Lange JR, Balch CM. Jacobs LK, et al. Ann Surg Oncol. 2008 May;15(5):1280-1. doi: 10.1245/s10434-008-9823-3. Epub 2008 Mar 5. Ann Surg Oncol. 2008. PMID: 18320286 Free PMC article. No abstract available.
Primary breast sarcoma.
Lum YW, Jacobs L. Lum YW, et al. Surg Clin North Am. 2008 Jun;88(3):559-70, vi. doi: 10.1016/j.suc.2008.03.009. Surg Clin North Am. 2008. PMID: 18514698 Review.
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
Balmanoukian A, Zhang Z, Jeter S, Slater S, Armstrong DK, Emens LA, Fetting JH, Wolff AC, Davidson NE, Jacobs L, Lange J, Tsangaris TN, Zellars R, Gabrielson E, Stearns V. Balmanoukian A, et al. J Clin Oncol. 2009 Aug 1;27(22):e35-7; author reply e38-9. doi: 10.1200/JCO.2008.21.5509. Epub 2009 Jun 29. J Clin Oncol. 2009. PMID: 19564528 Free PMC article. No abstract available.
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.
Chumsri S, Jeter S, Jacobs LK, Nassar H, Armstrong DK, Emens LA, Fetting JH, Lange JR, Riley C, Tsangaris TN, Wolff AC, Zellars R, Zhang Z, Stearns V. Chumsri S, et al. Among authors: jacobs lk. Clin Breast Cancer. 2010 Feb;10(1):40-5. doi: 10.3816/CBC.2010.n.005. Clin Breast Cancer. 2010. PMID: 20133257
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer.
Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, Tarpinian K, Brown RJ, Lange JR, Rudek MA, Zhang Z, Tsangaris TN, Sukumar S. Stearns V, et al. Among authors: jacobs lk. Sci Transl Med. 2011 Oct 26;3(106):106ra108. doi: 10.1126/scitranslmed.3002368. Sci Transl Med. 2011. PMID: 22030751 Free PMC article. Clinical Trial.
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.
Stearns V, Jacobs LK, Fackler M, Tsangaris TN, Rudek MA, Higgins M, Lange J, Cheng Z, Slater SA, Jeter SC, Powers P, Briest S, Chao C, Yoshizawa C, Sugar E, Espinoza-Delgado I, Sukumar S, Gabrielson E, Davidson NE. Stearns V, et al. Among authors: jacobs lk. Clin Cancer Res. 2013 Jul 15;19(14):4008-16. doi: 10.1158/1078-0432.CCR-13-0033. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719261 Free PMC article. Clinical Trial.
82 results